RESTON, Va.-Ralph Becker, mayor of Salt Lake City, Utah, has issued an official proclamation declaring June 5­[<00AD>]–9 "Molecular Imaging Days," coinciding with SNM's 57th Annual Meeting-one of the world's largest events focusing exclusively on fulfilling the educational and networking needs of the molecular imaging and therapy community.

"This is the first time that we have held our meeting in Salt Lake City," said Michael M. Graham, Ph.D., M.D., president of SNM. "Meeting attendees will have an opportunity to experience a beautiful city as they learn about advances in the field of molecular imaging to improve patient care."

SNM's Annual Meeting will bring together more than 6,000 members of the molecular imaging and nuclear medicine community, including physicians, technologists, scientists, physicists and pharmacists, to learn and share research about advances in the practice of molecular imaging and therapy.
Peter Herscovitch, M.D., chair of SNM's Scientific Program Committee, said, "There is no other event this large for nuclear medicine and molecular imaging scientists and practitioners. A top-notch educational and scientific program, exceptional networking opportunities and an attractive destination are just a few of the reasons why this year's meeting is a must-attend."

Annually, more than 20 million men, women and children undergo safe, noninvasive molecular imaging procedures with state-of-the-art imaging technologies-including PET and SPECT scans-to "photograph" biological targets or pathways in the body to help diagnose and treat disease and to evaluate how well treatment is working.

Molecular imaging is at the forefront of "personalized medicine" by providing patient-specific information that allows tailored treatment of disease. It is helping to advance the understanding, diagnosis, treatment and follow-up of cancer, cardiovascular disease and neurological disorders to improve the lives of people worldwide.

The mayor calls on all residents of the community to understand the benefits-historical, current and future-of molecular imaging and therapy.



About SNM-Advancing Molecular Imaging and Therapy

SNM is an international scientific and medical organization dedicated to raising public awareness about what molecular imaging is and how it can help provide patients with the best health care possible. SNM members specialize in molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated.

SNM's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snm.org.

More HCB News